Theravance Biopharma (TBPH)
(Delayed Data from NSDQ)
$8.55 USD
-0.43 (-4.79%)
Updated May 23, 2024 04:00 PM ET
After-Market: $8.55 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth A Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/05/2024
Time: -- |
6/2024 | $-0.10 | 22.41% |
Earnings Summary
For their last quarter, Theravance Biopharma (TBPH) reported earnings of -$0.09 per share, beating the Zacks Consensus Estimate of $-0.19 per share. This reflects a positive earnings surprise of 52.63%. Look out for TBPH's next earnings release expected on August 05, 2024. For the next earning release, we expect the company to report earnings of -$0.10 per share, reflecting a year-over-year increase of 23.08%.
Earnings History
Price & Consensus
Zacks News for TBPH
Theravance Biopharma (TBPH) Reports Q1 Loss, Misses Revenue Estimates
TBPH: What are Zacks experts saying now?
Zacks Private Portfolio Services